Velico Medical

Velico Medical is a U.S.-based medtech company developing a novel spray-dried plasma manufacturing system to address critical gaps in trauma and emergency care. Its core innovation, the FrontlineODP™ System, aims to transform fresh frozen plasma into a rapidly rehydratable, storable powder, enabling pre-hospital and point-of-care use in civilian EMS, military, and mass casualty settings. The company is in the clinical stage, building out manufacturing operations and engaging with key stakeholders across government, military, and blood banking sectors. With a history spanning over two decades of blood research and a robust patent portfolio, Velico is positioning itself to commercialize a product with significant potential to improve outcomes in hemorrhage control.

FrontlineODP™ Spray Dried Plasma Manufacturing System: An integrated platform for blood centers to convert liquid plasma into a stable, rapidly rehydratable powder through an automated spray-drying process, enabling point-of-care and pre-hospital use.

Velico competes in the emerging field of dried plasma products. Potential competitors include other private companies (e.g., Entegrion's Resusix, though development status varies) and government-sponsored research programs. The competitive advantage hinges on the integrated manufacturing system for blood centers, IP portfolio, and progress in clinical development and partnerships.